Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07059884 · ClinicalTrials.gov registry record · NA
Distance-Based Exercise to Preserve Function and Prevent Disability
A NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm, sponsored by Alliance for Clinical Trials in Oncology.
- Recruiting
- Registry status
- NA
- Development phase
- 104
- Enrollment target
- 14
- Study locations
NCT07059884: Recruiting NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm, sponsored by Alliance for Clinical Trials in Oncology.
NCT07059884 is a NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm that is actively recruiting participants, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 104 participants, below the 481-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (78% lower). The trial reports 14 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07059884, a NA study of Hematopoietic and Lymphatic System Neoplasm and Localized Malignant Solid Neoplasm, is actively recruiting participants, sponsored by Alliance for Clinical Trials in Oncology.
- RECRUITING
- Registry status
- NA
- Development phase
- 104 participants
- Enrollment target
- 14
- Study locations
Study Summary
This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side effects can make it difficult to work, take care of family, and do other things the patient wants to do. Preliminary research shows that exercise can help prevent some of these side effects, but it can be more difficult to start an exercise program when a patient is receiving cancer treatment. The exercise program in this study is delivered through telehealth (TH) video calls. The TH sessions are delivered by trained staff that supervise resistance exercises. The trained staff also provide guidance to the patient on completing unsupervised aerobic sessions on their own. This may be a successful way to deliver an exercise program and make it easier for cancer patients to exercise in their own home during treatment.
Primary Outcome
Feasibility will be defined through intervention adherence. Will set a priori thresholds for this outcome to define success as detailed. For evaluating the uptake of the intervention, will assess the percentage of enrolled participants who complete at least 70% of prescribed exercise sessions. Will calculate the proportion of participants meeting this threshold and compare it to the predefined success criterion of 80%. Descriptive statistics (percentages) will be reported along with 95% confiden
Conditions Studied
Interventions
- OTHER Telemedicine
- PROCEDURE Accelerometry
- OTHER Exercise intervention
- OTHER Aerobic Exercise Intervention
- OTHER Dumbbell Exercise Intervention
Study Locations (14)
California
- Kaiser Permanente Dublin - Dublin
- Kaiser Permanente-Fremont - Fremont
- Kaiser Permanente Fresno Orchard Plaza - Fresno
- Kaiser Permanente-Modesto - Modesto
- Kaiser Permanente-Oakland - Oakland
- Kaiser Permanente-South Sacramento - Sacramento
- Kaiser Permanente-Santa Teresa-San Jose - San Jose
- Kaiser San Rafael-Gallinas - San Rafael
- Kaiser Permanente-Vallejo - Vallejo
Pennsylvania
- UPMC Hillman Cancer Center at Butler Health System - Butler
- IRMC Cancer Center - Indiana
- UPMC Hillman Cancer Center - New Castle - New Castle
- UPMC Cancer Center at UPMC Northwest - Seneca
Massachusetts
- Dana-Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2026-02-11 |
| Est. Completion | 2027-02-18 |
| Phase | NA |
What NCT07059884 shows while recruiting
NCT07059884 is an interventional study that assigns participants to a tested intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap, below the 481-participant average among 62 other Hematopoietic and Lymphatic System Neoplasm trials with a reported enrollment target (78% lower).
The record links to 2 conditions, with Hematopoietic and Lymphatic System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Telemedicine is the first listed.
NCT07059884 lists 14 locations in 3 states (California, Pennsylvania, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT07059884 about?
NCT07059884 is a clinical study titled "Distance-Based Exercise to Preserve Function and Prevent Disability". This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side ef...
What is the current status of trial NCT07059884?
This trial is currently recruiting. It is a NA study. The enrollment target is 104 participants. The study started on 2026-02-11. Estimated completion is 2027-02-18.
What conditions does trial NCT07059884 study?
This clinical trial studies the following conditions: Hematopoietic and Lymphatic System Neoplasm, Localized Malignant Solid Neoplasm.
What interventions are being tested in trial NCT07059884?
The interventions under investigation include: Telemedicine (OTHER), Accelerometry (PROCEDURE), Exercise intervention (OTHER), Aerobic Exercise Intervention (OTHER), Dumbbell Exercise Intervention (OTHER).
Who is sponsoring clinical trial NCT07059884?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07059884 being conducted?
This trial has 14 study locations across California, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hematopoietic and Lymphatic System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07059884's enrollment target sits among peer trials
104 24th of 62 higher than 39 of 62 other Hematopoietic and Lymphatic System Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hematopoietic and Lymphatic System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Genetic Testing for the Prevention of Cancer in Indigenous American Communities (JUNIPER Trial)
RECRUITING · NA
-
Acupressure for the Reduction of Anxiety in Patients Receiving Cancer-Directed Therapy
RECRUITING · NA
-
Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting
RECRUITING · NA
-
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment
RECRUITING · NA
-
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
RECRUITING · NA
-
Different Types of Massage Therapy to Reduce Anxiety During Chemotherapy Infusion in Patients With Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI